Research Article - (2009) Volume 1, Issue 2
Prevention of Human Immunodeficiency Virus Type 1 Transmission by Pharmaceuticals Targeted to Host Proteins Required for Virus Infection? Consideration of Farnesyl Thiosalicylic Acid, a Ras Inhibitor
- A Robert Neurath1* and Carol Lackman-Smith2
- 1Virotech, 1496 Hemlock Farms, Hawley, PA 18428, USA, E-mail: arneurath@att.net
- 2Southern Research Institute, 431 Aviation Way, Frederick, Maryland 21701, USA, E-mail: arneurath@att.net
*Corresponding Author:
A Robert Neurath, Virotech, 1496 Hemlock Farms, Hawley, PA 18428, USA, Tel: (570) 775 7877 or (212) 529 4584
Email:
